What is Nostr?
clacke: seeking πŸ‡ΈπŸ‡ͺπŸ‡­πŸ‡°πŸ’™πŸ’› /
npub1njz…q92f
2025-02-15 03:01:01
in reply to nevent1q…mv5k

clacke: seeking πŸ‡ΈπŸ‡ͺπŸ‡­πŸ‡°πŸ’™πŸ’› on Nostr: "On 19 December [2023], JN.1 was declared by the WHO to be a variant of interest ...

"On 19 December [2023], JN.1 was declared by the WHO to be a variant of interest independently of its parent strain BA.2.8, but overall risk for public health was determined as low."

"The CDC estimated that the variant accounted for 44% of cases in the US on 22 December 2023 and 62% of cases on 5 January 2024."

"As of 9 February 2024 [ . . . ] (70–90% prevalence in four out of six global regions"

"XBB.1.5 booster [ . . . ] was expected to provide some protection (cross-reactivity) to JN.1."

"As of September 2024, XEC, first found in Germany, is expected to be the next major variant. XEC is a recombination of two subvariants: KS.1.1 and KP.3.3."

en.wikipedia.org/wiki/Variants…
Author Public Key
npub1njzrf5yyyfwent50am07cl0anquqrtcce9qsvqv7lc7kvuu3h77qezq92f